Literature DB >> 17308918

How early? ASAP: molecular and functional imaging!

Giovanni Lucignani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17308918     DOI： 10.1007/s00259-007-0381-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  13 in total

1.  PET of brain amyloid and tau in mild cognitive impairment.

Authors:  Gary W Small; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Susan Y Bookheimer; Karen J Miller; Helen Lavretsky; Alison C Burggren; Greg M Cole; Harry V Vinters; Paul M Thompson; S-C Huang; N Satyamurthy; Michael E Phelps; Jorge R Barrio
Journal:  N Engl J Med       Date:  2006-12-21       Impact factor: 91.245

Review 2.  Positron-emission tomography and assessment of cancer therapy.

Authors:  Malik E Juweid; Bruce D Cheson
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

3.  Early in vivo assessment of angiostatic therapy efficacy by molecular MRI.

Authors:  Willem J M Mulder; Daisy W J van der Schaft; Petra A I Hautvast; Gustav J Strijkers; Gerben A Koning; Gert Storm; Kevin H Mayo; Arjan W Griffioen; Klaas Nicolay
Journal:  FASEB J       Date:  2007-01-03       Impact factor: 5.191

4.  Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.

Authors:  Christian R A Mondadori; Andreas Buchmann; Henrietta Mustovic; Conny F Schmidt; Peter Boesiger; Roger M Nitsch; Christoph Hock; Johannes Streffer; Katharina Henke
Journal:  Brain       Date:  2006-09-29       Impact factor: 13.501

5.  Monitoring targeted therapy: is fluorodeoxylucose uptake a marker of early response?

Authors:  Hannah M Linden; Kenneth A Krohn; Robert B Livingston; David A Mankoff
Journal:  Clin Cancer Res       Date:  2006-10-01       Impact factor: 12.531

6.  [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.

Authors:  Coralie Chaise; Emmanuel Itti; Yolande Petegnief; Evelyne Wirquin; Christiane Copie-Bergman; Jean-Pierre Farcet; Marie-Hélène Delfau-Larue; Michel Meignan; Jean-Noël Talbot; Valérie Molinier-Frenkel
Journal:  Cancer Immunol Immunother       Date:  2006-12-14       Impact factor: 6.968

7.  The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage.

Authors:  Keiichi Jingu; Tomohiro Kaneta; Kenji Nemoto; Azusa Ichinose; Minako Oikawa; Yoshihiro Takai; Yoshihiro Ogawa; Eiko Nakata; Toru Sakayauchi; Kenji Takai; Toshiyuki Sugawara; Kakutaro Narazaki; Hiroshi Fukuda; Shoki Takahashi; Shogo Yamada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-01       Impact factor: 7.038

8.  Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors.

Authors:  Helen Su; Claudia Bodenstein; Rebecca A Dumont; Yann Seimbille; Steven Dubinett; Michael E Phelps; Harvey Herschman; Johannes Czernin; Wolfgang Weber
Journal:  Clin Cancer Res       Date:  2006-10-01       Impact factor: 12.531

9.  Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.

Authors:  Teresa Szyszko; Adil Al-Nahhas; Ruben Canelo; Nagy Habib; Long Jiao; Harpreet Wasan; Margarita Pagou; Paul Tait
Journal:  Nucl Med Commun       Date:  2007-01       Impact factor: 1.690

10.  Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.

Authors:  Lisa Mosconi; Sandro Sorbi; Mony J de Leon; Yi Li; Benedetta Nacmias; Paul S Myoung; Wai Tsui; Andrea Ginestroni; Valentina Bessi; Mozghan Fayyazz; Paolo Caffarra; Alberto Pupi
Journal:  J Nucl Med       Date:  2006-11       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.